Rahul D. Ballal, a director at Enliven Therapeutics, Inc. (NASDAQ:ELVN), recently made headlines in the market by selling 13,278 shares of the company’s common stock. This transaction took place on March 20, 2024, with Ballal disposing of the shares at prices ranging from $19.005 to $19.405, resulting in a total sale amount of approximately $254,462.
Wall Street
Consumer Portfolio Services, Inc. (NASDAQ:CPSS) recently finalized a $50 million securitization deal involving residual interests from its previous securitizations. The company sold asset-backed notes to a qualified institutional buyer, with the notes secured by an 80% interest in a CPS affiliate. This affiliate holds residual interests in five CPS securitizations issued between January 2022 and
On Thursday, JPMorgan shocked investors by lowering its price target for Pinduoduo Inc. (NASDAQ:PDD) from $195 to $190. Despite maintaining an Overweight rating, this move raised concerns among stakeholders about the future performance of the leading Chinese e-commerce platform. The adjustment came on the heels of Pinduoduo’s fourth-quarter earnings report, which showed solid growth but
Elon Musk’s brain-chip startup, Neuralink, made headlines with its livestream of the first patient successfully implanted with a chip that allows him to play online chess using only his mind. The patient, Noland Arbaugh, who was paralyzed below the shoulder after a diving accident, was able to control a computer cursor and keyboard using the
A bipartisan group of U.S. lawmakers recently sent a letter to the Biden administration, urging them to impose higher tariffs on Chinese drones, as well as drones shipped from other countries. The lawmakers, including Representative Mike Gallagher and Democrat Raja Krishnamoorthi, expressed concerns about the national and economic security threats posed by Chinese drone manufacturers